Item 2.02. Results of Operations and Financial Condition.



On August 12, 2022, PhaseBio Pharmaceuticals, Inc. (the "Company") reported
financial results for the second quarter ended June 30, 2022. A copy of this
press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K
and is incorporated by reference.

The information in this Item 2.02 of this Current Report on Form 8-K, including
Exhibit 99.1, is being furnished pursuant to Item 2.02 and shall not be deemed
"filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), or otherwise subject to the liabilities of that
section, nor shall it be deemed incorporated by reference in any filing under
the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange
Act, except as expressly set forth by specific reference in such filing to this
item of this report.

Item 7.01. Regulation FD Disclosure.



On August 12, 2022, the Company updated its corporate presentation for use in
meetings with investors, analysts and others. The presentation is available
through the Company's website and a copy is attached as Exhibit 99.2 to this
Current Report on Form 8-K.

The information in this Item 7.01 of this Current Report on Form 8-K, including
Exhibit 99.2, is being furnished pursuant to Item 7.01 and shall not be deemed
"filed" for purposes of Section 18 of the Exchange Act or otherwise subject to
the liabilities of that section, nor shall it be deemed incorporated by
reference in any filing under the Securities Act or the Exchange Act, whether
made before or after the date hereof, except as expressly set forth by specific
reference in such filing to this item of this report.

Item 9.01 Financial Statements and Exhibits.



(d)  Exhibits
    Exhibit No.                                            Description

                             Press Release, dated August 12, 2022, entitled "PhaseBio Pharmaceuticals
                           Reports Second Quarter 2022 Financial Results and Recent Business
99.1                       Highlights".
99.2                         Corporate Presentation, dated August 12, 2022.

104                        Cover page interactive data file (formatted as Inline XBRL).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses